111487 ⎘
ssRNA viruses positive-sense; Details; Picornaviridae; Aphthovirus, e.g. footandmouth disease virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
RECOMBINANT PROTEIN COMPRISING PROTEIN DERIVED FROM FOOT-AND-MOUTH DISEASE VIRUS TYPE O CAPSID PROTEIN AND SFC PROTEIN AND USE THEREOF
#2RECOMBINANT FOOT-AND-MOUTH DISEASE VIRUS TYPE O FOR INDUCING ROBUST ADAPTIVE IMMUNE RESPONSE AND OVERCOMING MATERNALLY-DERIVED ANTIBODY INTERFERENCE, AND FOOT-AND-MOUTH DISEASE VACCINE COMPOSITION COMPRISING SAME
#3DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA
#4T-CELL EPITOPE POLYPEPTIDE OF FOOT AND MOUTH DISEASE VIRUS AND USES THEREOF
#5STABLE EMULSIONS OF ANTIGENS
#6RECOMBINANT BACULOVIRUSES, VACCINE COMPOSITIONS THAT COMPRISE IT, AND METHODS FOR INDUCING AN IMMUNE RESPONSE
#7METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE
#8FMDV VIRUS-LIKE PARTICLE WITH DOUBLE STABILIZING MUTATION
#9Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom
#10FMDV VIRUS-LIKE PARTICLE WITH STABILIZING MUTATION
#11METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE
#12Foot-and-mouth disease vaccine
#13BACULOVIRUS EXPRESSION VECTOR
#14FOOT-AND-MOUTH DISEASE VIRUS-LIKE PARTICLE ANTIGEN, VACCINE COMPOSITION, PREPARATION METHOD, AND USE THEREOF
#15Foot-and-mouth disease vaccine
#16METHOD OF PURIFYING VIRUS-LIKE PARTICLES
#17Recombinant foot-and-mouth disease virus with reduced immunosuppression activity, and preparation method and use thereof
#18Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#19Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof
#20Recombinant Modified Vaccinia Virus Ankara (MVA) Foot and Mouth Disease Virus (FMDV) Vaccine
#21Method of purifying virus-like-particles
#22Recombinant virus capable of stably expressing target proteins
#23UNIVERSAL VACCINE FOR VIRAL DISEASES
#24Genetically engineered foot and mouth disease virus and related proteins, polynucleotides, compositions, methods and systems
#25Recombinant bivalent inactivated vaccine against foot-and-mouth disease virus, preparation method and use thereof
#26Foot-and-mouth disease vaccine
#27Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#28Method for preparing foot-and-mouth disease vaccines
#29FOOT AND MOUTH DISEASE VIRUS SEROTYPE O (FMDV-O) VACCINE
#30Method for purifying and concentrating inactivated antigen of foot-and-mouth disease virus
#31Vaccines and pharmaceutical compositions against foot-and-mouth disease virus
#32DNA vaccines against foot-and-mouth disease virus
#33Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modified FMDV 3C protease
#34Processing engineered FMDV P1 polypeptide using an alternative TEV protease
#35Universal vaccine for viral diseases
#36Stabilised FMDV capsids
#37Recombinant adenovirus vectored FMDV vaccines and uses thereof
#38Mineralized foot-and-mouth disease virus like particles, and preparation method and use thereof
#39Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
#40MONOCLONAL ANTIBODY AGAINST NOVEL EPITOPES OF FOOT-AND-MOUTH DISEASE VIRUS PROTEIN 3ABC AND USES THEREOF
#41Genetically engineered Foot and Mouth Disease Virus and related proteins, polynucleotides, compositions, methods and systems
#42Foot-and-mouth disease vaccine
#43Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof
#44Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof
#45Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease
#46Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccine
#47FMDV and E2 fusion proteins and uses thereof
#48Hand, foot, and mouth vaccines and methods of manufacture and use thereof
#49Mosaic vaccines for serotype a foot-and-mouth disease virus
#50Whole expressed cell as antigen carrier, and use thereof in preparing vaccine or diagnostic agent, and screening monoclonal antibodies
#51Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof
#52Attenuated vaccines and methods of making and use thereof
#53Monoclonal antibody against novel epitopes of foot-and-mouth disease virus protein 3ABC and uses thereof
#54Recombinant adenovirus vectored FMDV vaccines and uses thereof
#55VACCINES WITH INTERLEUKIN-17 AS AN ADJUVANT
#56Methods of making and using vaccines utilizing minicircle DNA expression vectors for production of foot-and-mouth-disease virus proteins and virus-like particles
#57FMDV and E2 fusion proteins and uses thereof
#58Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
#59Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#60Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#61FMDV recombinant vaccines and uses thereof
#62Stabilised FMDV capsids
#63Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#64Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#65Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)
#66Nonspecific immunostimulator composition, method of preparation the same, and its use
#67Vaccine formulations comprising saponin-containing adjuvants
#68METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS
#69Isolated nucleic acid for the production of a vaccine against virus
#70Attenuated vaccines and methods of making and use thereof
#71Methods and compositions to protect aquatic invertebrates from disease
#72Modified foot and mouth disease virus (FMDV) VP1 capsid protein
#73Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#74Expression cassette for efficient surface display of antigenic proteins
#75Foot and mouth disease virus with increased stability and its use as vaccine
#76Method of rapidly producing improved vaccines for animals
#77Methods and compositions to protect aquatic invertebrates from disease
#78Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
#79Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#80Methods and compositions to protect aquatic invertebrates from disease
#81METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS
#82VIRAL VACCINE AND PROCESS FOR PREPARING THE SAME
#83Method for keeping an immunogenic composition available for administration to an animal
#84METHOD FOR KEEPING A FOOT-AND-MOUTH DISEASE VACCINE AVAILABLE FOR EMERGENCY VACCINATION
#85Vaccine
#86Anti-FMD vaccine composition and preparation and use thereof
#87Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region
#88Vaccine formulations comprising saponin-containing adjuvants
#89CHIMERIC FOOT AND MOUTH DISEASE VIRUSES
#90Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system
#91Double-effective vaccine vector against foot-and-mouth disease virus (FMDV), methods of preparing and using the same
#92Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#93Adenoviral vector-based foot-and-mouth disease vaccine
#94AVIPOX RECOMBINANTS EXPRESSING FOOT AND MOUTH DISEASE VIRUS GENES
#95VP1 of foot-and-mouth disease virus
#96Avipox recombinants expressing foot and mouth disease virus genes
#97Protein sequences containing antigenized antibodies for foot-and-mouth disease
#98Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#99Coronavirus-like particles comprising functionally deleted genomes
#100Immunogenic peptides of foot-and-mouth disease viruses
#101Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host